A call to reprioritise metrics to evaluate illicit drug policy.
Division of Global Public Health, University of California San Diego, San Diego, CA, USA; International Centre for Science in Drug Policy, Toronto, ON M5B 1W8, Canada. Electronic address: dwerb@ucsd.edu.
Dan
D
Werb
Global Commission on Drug Policy, Botafogo, Rio de Janeiro, Brazil.
Michel
M
Kazatchkine
Urban Health Research Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Thomas
T
Kerr
Division of Brain Sciences, Imperial College London, London, UK.
David
D
Nutt
Division of Global Public Health, University of California San Diego, San Diego, CA, USA.
Steffanie
S
Strathdee
Department of Global Health, University of Amsterdam, Amsterdam, Netherlands.
Catherine
C
Hankins
Urban Health Research Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Kanna
K
Hayashi
British Columbia Centre for Excellence in HIV/AIDS, Vancouva, BC, Canada.
Julio
J
Montaner
Center for Drug Use and HIV Research, New York University College of Nursing, New York, NY, USA.
Don Des
DD
Jarlais
International Centre for Science in Drug Policy, Toronto, ON M5B 1W8, Canada.
Nazlee
N
Maghsoudi
Division of Global Public Health, University of California San Diego, San Diego, CA, USA.
Evan
E
Wood
D003226:Congresses as Topic; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006292:Health Priorities; D006801:Humans; D038622:Internationality; D035846:Law Enforcement; D011634:Public Health; D011049:Social Control Policies; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000517:prevention & control*; D014480:United Nations